Rocket Pharmaceuticals, Inc. Share Price & Technical Analysis
RCKT · $2.96 (-4.82%)
Healthcare / Biotechnology
$2.96
-4.82%
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States. It develops in vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading t…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-14% return in May, -18% avg return in past 3 year May month.
3% return in 2026, -27% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 0% | 47% | -27% | -3% | -14% | – | – | – | – | – | – | – | 3% |
| 25 | -16% | -10% | -29% | 15% | -68% | 0% | 25% | 10% | 0% | 19% | -8% | 6% | -55% |
| 24 | -3% | 2% | -9% | -20% | -2% | 0% | 14% | -22% | -2% | -10% | -14% | -12% | -79% |
| 23 | 9% | -14% | -11% | 5% | 17% | -5% | -10% | -13% | 30% | -12% | 29% | 29% | 54% |
| 22 | -24% | 4% | -11% | -36% | 17% | 15% | 5% | 7% | 5% | 15% | -2% | 4% | -2% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States. It develops in vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), which is in Phase 2 trial; Plakophilin-2 Arrhythmogenic Cardiomyopathy (PKP2-ACM), an inheritable cardiac disorder that is characterized by a progressive loss of cardiac muscle mass, severe right ventricular dilation, dysplasia, fibrofatty replacement of the myocardium and a high propensity to arrhythmias and sudden death (RP-A601), which is in phase 1; and BAG3 Dilated Cardiomyopathy (BAG3-DCM), which is a form of cardiomyopathy and is characterized by progressive thinning of the walls of the heart, which is in preclinical stage. It also develops ex vivo lentiviral (LV) programs, which include programs for Leukocyte Adhesion Deficiency-I (LAD-I), a genetic disorder that causes the immune system to malfunction (RP-L201); Fanconi Anemia (FA), a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells (RP-L102); and Pyruvate Kinase Deficiency (PKD), a red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia (RP-L301). It has license agreements with Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Centro de Investigacion Biomedica En Red de Enfermedades Raras, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; UCL Business PLC; The Regents of the University of California; and Temple University. Rocket Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Cranbury, New Jersey.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$398.56M
P/E ratio
—
52W high
$5.45
52W low
$2.19
Volume
21,11,788
Beta
0.52
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Rocket Pharmaceuticals, Inc. share price today?
- Rocket Pharmaceuticals, Inc. (RCKT) last traded around $2.96 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does RCKT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for RCKT. Download the app for real-time alerts.
- How can I analyze Rocket Pharmaceuticals, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.